메뉴 건너뛰기




Volumn 76, Issue 6, 2012, Pages 1324-1325

What type of Statin and what level of low-density lipoprotein cholesterol should be appropriate for secondary prevention for Japanese patients with coronary artery disease?

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN;

EID: 84861581794     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0503     Document Type: Editorial
Times cited : (1)

References (14)
  • 1
    • 15944410609 scopus 로고    scopus 로고
    • Intensive lipid lowering with atorvastatin in patients with stable coronary disease
    • LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-1435.
    • (2005) N Engl J Med , vol.352 , pp. 1425-1435
    • Larosa, J.C.1    Grundy, S.M.2    Waters, D.D.3    Shear, C.4    Barter, P.5    Fruchart, J.C.6
  • 2
    • 33748952489 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): A prospective randomised controlled trial
    • Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): A prospective randomised controlled trial. Lancet 2006; 368: 1155-1163.
    • (2006) Lancet , vol.368 , pp. 1155-1163
    • Nakamura, H.1    Arakawa, K.2    Itakura, H.3    Kitabatake, A.4    Goto, Y.5    Toyota, T.6
  • 3
    • 79953662888 scopus 로고    scopus 로고
    • Impact of low density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention
    • Matsumoto I, Miyake Y, Mizukawa M, Takagi Y. Impact of low density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention. Circ J 2011; 75: 905-910.
    • (2011) Circ J , vol.75 , pp. 905-910
    • Matsumoto, I.1    Miyake, Y.2    Mizukawa, M.3    Takagi, Y.4
  • 4
    • 84861594738 scopus 로고    scopus 로고
    • Intensity of statin therapy, achieved LDL-C levels and cardiovascular outcomes in Japanese patients after coronary revascularization: Perspectives from the CREDO-Kyoto Registry Cohort-2
    • On behalf of the CREDO-Kyoto PCI/CABG registry cohort-2 investigators
    • Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, et al. On behalf of the CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Intensity of statin therapy, achieved LDL-C levels and cardiovascular outcomes in Japanese patients after coronary revascularization: Perspectives from the CREDO-Kyoto Registry Cohort-2. Circ J 2012; 76: 1369-1379.
    • (2012) Circ J , vol.76 , pp. 1369-1379
    • Natsuaki, M.1    Furukawa, Y.2    Morimoto, T.3    Nakagawa, Y.4    Ono, K.5    Kaburagi, S.6
  • 5
    • 33645737679 scopus 로고    scopus 로고
    • Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese
    • Sakamoto T, Kojima S, Ogawa H, Shimomura H, Kimura K, Ogata Y, et al. Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese. Am J Cardiol 2006; 97: 1165-1171.
    • (2006) Am J Cardiol , vol.97 , pp. 1165-1171
    • Sakamoto, T.1    Kojima, S.2    Ogawa, H.3    Shimomura, H.4    Kimura, K.5    Ogata, Y.6
  • 6
    • 39849090518 scopus 로고    scopus 로고
    • Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: The OACISLIPID Study
    • Sato H, Kinjo K, Ito H, Hirayama A, Nanto H, Fukunami M, et al. Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: The OACISLIPID Study. Circ J 2008; 72: 17-22.
    • (2008) Circ J , vol.72 , pp. 17-22
    • Sato, H.1    Kinjo, K.2    Ito, H.3    Hirayama, A.4    Nanto, H.5    Fukunami, M.6
  • 7
    • 77955085510 scopus 로고    scopus 로고
    • Clinical significance of intensive lipid-lowering therapy using statins in patients with coronary artery disease: LDL-cholesterol: The lower, the better; is it true for Asians?
    • Miyauchi K, Daida H. Clinical significance of intensive lipid-lowering therapy using statins in patients with coronary artery disease: LDL-cholesterol: The lower, the better; is it true for Asians? (Pro) Circ J 2010; 74: 1718-1730.
    • (2010) Pro Circ J , vol.74 , pp. 1718-1730
    • Miyauchi, K.1    Daida, H.2
  • 8
    • 77955074057 scopus 로고    scopus 로고
    • Just make it lower is an alternative strategy of lipid-lowering therapy with statins in Japanese patients: LDL cholesterol: The lower, the better; is it true for Asians?
    • Sakamoto T, Ogawa H. "Just make it lower" is an alternative strategy of lipid-lowering therapy with statins in Japanese patients: LDL cholesterol: The lower, the better; is it true for Asians? (Con) Circ J 2010; 74: 1731-1741.
    • (2010) Con Circ J , vol.74 , pp. 1731-1741
    • Sakamoto, T.1    Ogawa, H.2
  • 9
    • 80052139677 scopus 로고    scopus 로고
    • Intensively loweringboth low-density lipoprotein cholesterol and blood pressure dose not reduce cardiovascular risk in Japanese coronary artery disease patients
    • On behalf of the JCADII Investigators
    • Kohro T, Yamazaki T, Izumi T, Daida H, Kurabayashi M, Miyauchi K, et al. On behalf of the JCADII Investigators. Intensively loweringboth low-density lipoprotein cholesterol and blood pressure dose not reduce cardiovascular risk in Japanese coronary artery disease patients. Circ J 2011; 75: 2062-2070.
    • (2011) Circ J , vol.75 , pp. 2062-2070
    • Kohro, T.1    Yamazaki, T.2    Izumi, T.3    Daida, H.4    Kurabayashi, M.5    Miyauchi, K.6
  • 10
    • 79952106340 scopus 로고    scopus 로고
    • Differential metabolic effects of distinct statins
    • Koh KK, Sakuma I, Quon MJ. Differential metabolic effects of distinct statins. Atherosclerosis 2011; 215: 1-8.
    • (2011) Atherosclerosis , vol.215 , pp. 1-8
    • Koh, K.K.1    Sakuma, I.2    Quon, M.J.3
  • 11
    • 84255172397 scopus 로고    scopus 로고
    • Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in japanese patients: Justification for Atherosclerosis Regression Treatment (JART) Study
    • Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, et al. Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in japanese patients: Justification for Atherosclerosis Regression Treatment (JART) Study. Circ J 2012; 76: 221-229.
    • (2012) Circ J , vol.76 , pp. 221-229
    • Nohara, R.1    Daida, H.2    Hata, M.3    Kaku, K.4    Kawamori, R.5    Kishimoto, J.6
  • 12
    • 84855833067 scopus 로고    scopus 로고
    • Caveats to aggressive lowering of lipids by specific statins
    • Koh KK, Lim S, Sakuma I, Quon MJ. Caveats to aggressive lowering of lipids by specific statins. Int J Cardiol 2012; 154: 97-101.
    • (2012) Int J Cardiol , vol.154 , pp. 97-101
    • Koh, K.K.1    Lim, S.2    Sakuma, I.3    Quon, M.J.4
  • 13
    • 67650738656 scopus 로고    scopus 로고
    • Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study
    • Kashima Y, Izawa A, Aizawa K, Koshikawa M, Kasai H, Tomita T, et al. Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study. J Cardiol 2009; 54: 76-79.
    • (2009) J Cardiol , vol.54 , pp. 76-79
    • Kashima, Y.1    Izawa, A.2    Aizawa, K.3    Koshikawa, M.4    Kasai, H.5    Tomita, T.6
  • 14
    • 84877730804 scopus 로고    scopus 로고
    • How to control residual cardiovascular risk despite statin treatment: Focusing on HDL-cholesterol
    • 2012 April 12, doi:10.1016/j.ijcard.2012.03.127
    • Lim S, Park YM, Sakuma I, Koh KK. How to control residual cardiovascular risk despite statin treatment: Focusing on HDL-cholesterol. Int J Cardiol 2012 April 12 [doi:10.1016/j.ijcard.2012.03.127].
    • Int J Cardiol
    • Lim, S.1    Park, Y.M.2    Sakuma, I.3    Koh, K.K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.